SIRT7 and central nervous system cancer: These results suggest that SIRT7 upregulation in gliomas may contribute to tumor progression, as evidenced by its significant overexpression in tumor tissues relative to normal controls and its positive correlation with histological grade advancement (Fig. 1E and F).